Of note, our results indicated that berberine pretreatment could suppress MPO activity in CS-induced COPD rats, and such an effect was highly improved by Ber-encapsulated SLN-chitosan nanoparticles. Here, MPO is linked to chronic obstructive pulmonary disease.